Search Results
Sep 08, 2026, 09:00 ET IMDELLTRA® IN COMBINATION WITH IMFINZI® DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
doi:10.7150/jca.75622.Sabari JK, Lok BH, Laird JH, Poirier JT, Rudin CM. Unravelling the biology of SCLC: implications for therapy. Nat Rev Clin Oncol. 2017;14(9):549-561. doi:10.1038/nrclinonc.2017.71.Cramer-van der Welle CM, Schramel FMNH, van Leeuwen AS, Groen HJM, van de Garde
More news about: Amgen
Sep 08, 2026, 08:15 ET 禮邦醫藥 AP308 治療 IgA 腎病的新藥臨床試驗申請獲美國 FDA 批准
2025;40(6):1137–1146.[3] Pitcher D, Braddon F, Hendry B, et al. Long-term outcomes in IgA nephropathy. Clin J Am Soc Nephrol. 2023;18(6):727–738.[4] 灼識咨詢（CIC）資料
More news about: 禮邦醫藥
Sep 08, 2026, 08:05 ET Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy
[3] Pitcher D, Braddon F, Hendry B, et al. Long-term outcomes in IgA nephropathy. Clin J Am Soc Nephrol. 2023;18(6):727–738.[4]
More news about: Alebund Pharmaceuticals
Sep 08, 2026, 08:00 ET Harmonic présente son tissu d'intelligence cOS SensAI pour les opérations haut débit
chaque diagnostic. Cette transparence a joué un rôle déterminant pour permettre à notre NOC et à nos équipes d'ingénieurs de résoudre les problèmes en un clin d'œil. Et surtout, nous sommes en mesure de nous intégrer aux systèmes existants pour offrir une vue d'ensemble complète. »« Chez GCI, nous relions
More news about: Harmonic Inc.
Sep 08, 2026, 08:00 ET Johnson & Johnson spotlights new neuropsychiatry data across bipolar mania, depression and schizophrenia at Psych Congress 2026
doi:10.1176/ajp.2006.163.Arnaud AM, Brister TS, Duckworth K, et al. Impact of major depressive disorder on comorbidities: a systematic literature review. J Clin Psychiatry. 2022;83(6):21r14328.Cao B, Zhu J, Zuckerman H, et al. Pharmacological interventions targeting anhedonia in patients with major
More news about: Johnson & Johnson
Sep 04, 2026, 09:05 ET Dimerix獲得3400萬澳元非稀釋性融資，為關鍵臨床裡程碑提供資金支持
https://doi.org/10.1001/jama.2022.1751.[11]Hobson C, Ruchi R, Bihorac A. Perioperative Acute Kidney Injury. Crit Care Clin 2017;33:379–96. https://doi.org/10.1016/j.ccc.2016.12.008
More news about: Dimerix Limited
Sep 04, 2026, 07:00 ET DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES
[11] Hobson C, Ruchi R, Bihorac A. Perioperative Acute Kidney Injury. Crit Care Clin 2017;33:379–96. https://doi.org/10.1016/j.ccc.2016.12.008
More news about: Dimerix Limited
Sep 03, 2026, 09:15 ET AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma
study of ABBV-383, a B-cell maturation antigen × CD3 bispecific T-cell redirecting antibody, in patients with relapsed/refractory multiple myeloma. J Clin Oncol. 2022;40(31):3576-3586. doi:10.1200/JCO.22.01504.
More news about: AbbVie
Sep 01, 2026, 04:49 ET Alcon's Clareon Monofocal IOL Receives EUMDR Certification Through TÜV SÜD
file, REF-24499, 2025 Micheletti JM, Duncan NB, Hall B. Head-to-Head Comparison of Intermediate Vision of Two Monofocal Intraocular Lenses. Clin Ophthalmol. 2023 Dec 21;17:3983-3990 Clareon Monofocal 30+ peer-reviewed studies evidence, REF-27708, 2025.
More news about: Alcon
Aug 31, 2026, 01:01 ET L'adoption rapide de Viso Now marque un tournant décisif dans la manière dont sont développées les applications de vision par ordinateur
des solutions de vision par ordinateur pouvant être déployées immédiatement. Les équipes peuvent passer d'une idée à une solution fonctionnelle en un clin d'œil, ce qui leur permet de tester plus facilement davantage de possibilités et de se concentrer sur les applications qui apportent une réelle valeur
More news about: viso.ai
Aug 27, 2026, 21:01 ET /C O R R E C T I O N -- O Positiv Health/
fielded to physicians from June 1, 2025 through May 31, 2026Dinh QQ, Sinclair R. Female pattern hair loss: current treatment concepts. Clin Interv Aging. 2007;2(2):189-199
More news about: O Positiv Health
Aug 27, 2026, 02:00 ET TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
Gastroenterol & Hepatol. 2023;20(2):101-119.Thel HL, et al. Prevalence and costs of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol. 2025;23(2):272-280.e8.Cleveland Clinic. Eosinophilic Esophagitis (EoE): Symptoms & Treatment. Available
More news about: Amgen
Aug 26, 2026, 09:17 ET VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets
of transcription factor protected cfDNA in plasma by ChIP-seq: measurement of altered CTCF binding in cancer is a novel biomarker for liquid biopsy. Clin Epigenet (2026). https://doi.org/10.1186/s13148-026-02205-xData
More news about: VolitionRx Limited
Aug 26, 2026, 07:00 ET HaemaLogiX Announces Major Milestone with First Patient Successfully Dosed with KMCAR™ T-Cell
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin., 2024; 74(3): 229-263; Hou Q, Li X, Ma H, Fu D, Liao A. A systematic epidemiological trends analysis study in global burden of multiple myeloma and
More news about: HaemaLogiX Ltd
Aug 25, 2026, 10:00 ET Mahzi Therapeutics Announces FDA Rare Pediatric Disease Designation for MZ-1866 Investigational Therapy for Pitt Hopkins Syndrome
Medicine (CIRM), a state of California Agency that funds regenerative medicine, stem cell, and gene therapy research (Grant Numbers TRAN1-13997 and CLIN2-19119).About the Phase 1/2 UNITE StudyThe Phase 1/2 UNITE clinical trial is an open-label study evaluating a single administration
More news about: MAHZI Therapeutics
Aug 24, 2026, 19:12 ET FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients
2025.9 Tranekær S, Hansen DL, Frederiksen H. Epidemiology of Secondary Warm Autoimmune Haemolytic Anaemia-A Systematic Review and Meta-Analysis. J Clin Med. 2021 Mar 17;10(6):1244. doi: 10.3390/jcm10061244. PMID: 33802848; PMCID: PMC8002719.10 Cherif, H., Cai, Q., Crivera, C., Leon,
More news about: Johnson & Johnson
Aug 24, 2026, 08:00 ET Avulux Granted FDA De Novo Authorization, Creating the First Lens Classification for Migraine-Associated Light Sensitivity
the intrinsically photosensitive retinal ganglion cell to reduce headache pain and light sensitivity in migraine: A randomized double-blind trial. J Clin Neurosci. 2023;113:22-31. doi:10.1016/j.jocn.2023.04.0159 Talbert C, Goturi N, Pondelis NJ, Aguilar MC, Gonzalez A, Durkee HA, Parel
More news about: Avulux
Aug 24, 2026, 05:35 ET European Commission grants orphan designation for Lundbeck's investigational anti-ACTH monoclonal antibody asedebart for Cushing's syndrome of endogenous origin
Endocrinol. 2021;9(12):847–875.Nieman LK, et al. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(8):2807–2831.Lundbeck. Data on file.Feldhaus AL, et al. Endocrinology. 2017;158(1):1–8.Xing
More news about: H. Lundbeck A/S
Aug 24, 2026, 05:33 ET European Commission grants orphan designation for Lundbeck's investigational anti-ACTH monoclonal antibody asedebart for Cushing's syndrome of endogenous origin
Endocrinol. 2021;9(12):847–875.Nieman LK, et al. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(8):2807–2831.Lundbeck. Data on file.Feldhaus AL, et al. Endocrinology. 2017;158(1):1–8.Xing
More news about: H. Lundbeck A/S
Aug 21, 2026, 07:45 ET AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline
Cooper AJ, et al. ABBV-706 as monotherapy and in combination with budigalimab in patients with relapsed/refractory (R/R) small cell lung cancer (SCLC). J Clin Oncol 44, 8008-8008 (2026).Chiang AC, Byers LA, Cooper AJ, et al. Hematologic and Gastrointestinal Toxicity of ABBV-706 in Advanced Solid Tumors:
More news about: AbbVie
Aug 18, 2026, 19:50 ET 헤일리온, 싱가포르 과학기술청과 아시아 여성의 대사 건강에 관한 새 임상 연구 착수
[3] Ou YJ, Lee JI, Huang SP, Chen SC, Geng JH, Su CH. Association between Menopause, Postmenopausal Hormone Therapy and Metabolic Syndrome. J Clin Med. 2023 Jun 30;12(13):4435. doi:
More news about: Haleon
Aug 18, 2026, 09:00 ET Kenai Therapeutics Appoints Mark Gergen to Board of Directors
Regenerative Medicine (CIRM), a state of California Agency that funds regenerative medicine, stem cell, and gene therapy research (Grant Numbers CLIN1-14300; CLIN2-19068).About Kenai Therapeutics Kenai Therapeutics is a clinical-stage biotechnology company pioneering next generation approaches
More news about: Kenai Therapeutics/BIOCOM
Aug 17, 2026, 03:21 ET HaleonとシンガポールのAgency for Science, Technology and Research（A*STAR）が、アジア人女性の代謝健康に関する新たな臨床研究を開始
Forum[3] Ou YJ, Lee JI, Huang SP, Chen SC, Geng JH, Su CH. Association between Menopause, Postmenopausal Hormone Therapy and Metabolic Syndrome. J Clin Med. 2023 Jun 30;12(13):4435. doi:
More news about: Haleon
Aug 13, 2026, 07:30 ET Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission
2021;161(1):113-121. 7. Vergote I, et al. J Clin Oncol. 2023;41(35):5400-5410. 8. Mirza
More news about: Karyopharm Therapeutics Inc.
Aug 11, 2026, 08:00 ET Synchrony Medical Enrolling Bronchiectasis Patients in Real-World Study to Evaluate Impact of LibAirty™ Airway Clearance System
https://libairty.health/.Helper N, Ashkenazi M, Sokol G, Dagan A, Efrati O. A Novel Medical Device for Airway Clearance. J Clin Med. 2025 Jan 30;14(3):907.Mingora C, Barfield W, Shani A, Tzfoni T, Flume P. Evaluation of the Safety and Efficacy of LibAirtyTM
More news about: Synchrony Medical